Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry (Q48407695)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 December 2014

Language	Label	Description	Also known as
English	Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry	scientific article published on 23 December 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

0 references

0 references

cannabinoid receptor

0 references

author name string

Guadalupe Muñoz-Arenas

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Francisco Paz-Bermúdez

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Ana Báez-Cordero

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

René Caballero-Florán

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Brenda González-Hernández

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Benjamín Florán

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

I Daniel Limón

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

publication date

23 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

69

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

103-114

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Concurrent activation of striatal direct and indirect pathways during action initiation.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Pathophysiology of parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

GABAergic modulation of the activity of globus pallidus neurons in primates: in vivo analysis of the functions of GABA receptors and GABA transporters

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Localization and function of GABA transporters in the globus pallidus of parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Modulation of Striatal Projection Systems by Dopamine

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Adenosine A2A receptor stimulation decreases GAT-1-mediated GABA uptake in the globus pallidus of the rat

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when G(i) protein-receptor coupling is restricted: role of dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

The CB1 cannabinoid receptor in the brain.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Past, present, and future of the pathophysiological model of the Basal Ganglia

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

The fetal hypothalamus has the potential to generate cells with a gonadotropin releasing hormone (GnRH) phenotype

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.21796

21 January 2018

Identifiers

10.1002/SYN.21796

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25522178

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48407695&oldid=2197832715"